Powered by

NextCure to Present at the JMP Securities Life Sciences Conference

Jun 10, 2021 - GlobeNewswire
Event Announcements

BELTSVILLE, Md., June 10, 2021 (GLOBE NEWSWIRE) -- (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced that it will participate in a fireside chat at the JMP Securities Life Sciences Conference on June 17 th at 1:30 pm Eastern time.

A live audio webcast will be available through the Investors section of the company’s website at . A r...